Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40C39 | ISIN: US5049221055 | Ticker-Symbol: N6B
Frankfurt
17.09.25 | 08:10
230,00 Euro
-0,86 % -2,00
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
LABCORP HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
LABCORP HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
232,00236,0023:00
232,00234,0021:59

Aktuelle News zur LABCORP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLabcorp Completes $225 Mln Acquisition Of BioReference Health's Oncology Testing Business329WASHINGTON (dpa-AFX) - Labcorp (LH) and OPKO Health, Inc. announced the completion of Labcorp's acquisition of select BioReference Health assets focused on oncology and oncology-related clinical...
► Artikel lesen
MoLabcorp Completes Acquisition of BioReference Health Assets3
MoLabcorp completes acquisition of BioReference Health oncology assets4
MoLabcorp Holdings Inc: Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses99BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO...
► Artikel lesen
09.09.Labcorp hebt Prognose an: Strategisches Wachstum im Fokus trotz regulatorischer Hürden2
28.08.LABCORP HOLDINGS INC. - 8-K, Current Report2
28.08.Dividendenbekanntmachungen (28.08.2025)10.935 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABC-MART INC  JP3152740001  35 JPY  0,204 EUR  ADASTRIA CO LTD  JP3856000009  45 JPY  0,2623 EUR  ADDTECH AB  SE0014781795  3,2 SEK  0...
► Artikel lesen
26.08.Is it the Right Time to Hold Labcorp Stock in Your Portfolio?4
LABCORP Aktie jetzt für 0€ handeln
19.08.Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up2
18.08.Labcorp launches FDA-cleared blood test for Alzheimer's disease4
18.08.Labcorp Announces Availability Of Lumipulse PTau-217/Beta Amyloid 42 Ratio For Alzheimer's Diagnosis330WASHINGTON (dpa-AFX) - Labcorp Holdings Inc. (LH), Monday announced the availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio, a blood-based in-vitro diagnostic test to aid in the diagnosis...
► Artikel lesen
18.08.Labcorp launches first FDA-cleared blood test for Alzheimer's disease3
18.08.Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease401 Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global...
► Artikel lesen
05.08.Covance Softsol Delivers Explosive Gains, Transforms Rs 1 Lakh Into Rs 13 Lakh In 6 Months4
01.08.LABCORP HOLDINGS INC. - 10-Q, Quarterly Report5
29.07.Labcorp Achieves IVDR CE-Marking for PGDx elio tissue complete in the EU394First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU BURLINGTON...
► Artikel lesen
25.07.Labcorp sticks up for stem cell donations by joining Gift of Life 'Hero Gum' campaign3
25.07.These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings2
25.07.10 Analysts Have This To Say About Labcorp Holdings5
25.07.Jefferies raises Laboratory Corporation of America price target to $3005
Weiter >>
107 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1